Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020

Nav

General Info

Geography

California, Georgia, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New York, North Dakota, Oklahoma, Pennsylvania, Puerto Rico, Tennessee, Texas, Vermont

Time period covered

01/2020 - 12/2020

Data type

Scientific literature

Keywords

COVID-19, Preterm birth, Disease outbreaks

Citation

Authors

Journal

MMWR Morb Mortal Wkly Rep

Volume

Issue

Pages

1635-1640

Publication year

2020

Suggested citation

Woodworth KR, Olsen EO, Neelam V, Lewis EL, Galang RR, Oduyebo T, Aveni K, Yazdy MM, Harvey E, Longcore ND, Barton J, Fussman C, Siebman S, Lush M, Patrick PH, Halai UA, Valencia-Prado M, Orkis L, Sowunmi S, Schlosser L, Khuwaja S, Read JS, Hall AJ, Meaney-Delman D, Ellington SR, Gilboa SM, Tong VT, CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, COVID-19 Pregnancy and Infant Linked Outcomes Team (PILOT). Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(44): 1635-1640.

DOI

10.15585/mmwr.mm6944e2

PMID

33151917

GHDx Entry last modified on: Mar 14, 2022

Header sites

Search form

Main menu

Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020

Nav